Addex Therapeutics Stock Price on December 4, 2024
| ADXN Stock | USD 7.92 0.08 1.00% |
Below is the normalized historical share price chart for Addex Therapeutics extending back to January 29, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Addex Therapeutics stands at 7.92, as last reported on the 11th of December 2024, with the highest price reaching 8.30 and the lowest price hitting 7.89 during the day.
If you're considering investing in Addex Stock, it is important to understand the factors that can impact its price. Addex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0505, which signifies that the company had a -0.0505% return per unit of standard deviation over the last 3 months. Addex Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Addex Therapeutics' mean deviation of 3.79, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide.
At this time, Addex Therapeutics' Common Stock Total Equity is very stable compared to the past year. As of the 11th of December 2024, Common Stock Shares Outstanding is likely to grow to about 78 M, while Total Stockholder Equity is likely to drop about 1.1 M. . As of the 11th of December 2024, Price To Sales Ratio is likely to drop to 2.01. In addition to that, Price Earnings Ratio is likely to drop to -0.34. Addex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of January 2020 | 200 Day MA 10.3398 | 50 Day MA 9.5168 | Beta 1.874 |
Addex |
Sharpe Ratio = -0.0505
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ADXN |
Estimated Market Risk
| 5.24 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Addex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Addex Therapeutics by adding Addex Therapeutics to a well-diversified portfolio.
Price Book 0.6794 | Enterprise Value Ebitda (0.76) | Price Sales 9.9065 | Shares Float 34.2 M | Wall Street Target Price 30 |
Related Headline
Larimar Therapeutics Headline on 4th of December 2024
Acquisition by Truitt Joseph of 8300 shares of Larimar Thera... by MacroaxisInsider
Filed transaction by Larimar Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Addex Therapeutics Valuation on December 4, 2024
It is possible to determine the worth of Addex Therapeutics on a given historical date. On December 4, 2024 Addex was worth 7.9 at the beginning of the trading date compared to the closed value of 7.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Addex Therapeutics stock. Still, in general, we apply an absolute valuation method to find Addex Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Addex Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Addex Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 8.10 | 8.84 | 7.86 | 7.97 | 132,912 | |
12/04/2024 | 7.90 | 8.10 | 7.14 | 7.20 | 113,181 |
| 7.18 | 8.20 | 7.18 | 7.53 | 40,694 |
| Backtest Addex Therapeutics | | | Addex Therapeutics History | | | Addex Therapeutics Valuation | Previous | Next |
Addex Therapeutics Trading Date Momentum on December 4, 2024
| On December 05 2024 Addex Therapeutics was traded for 7.53 at the closing time. The top price for the day was 8.20 and the lowest listed price was 7.18 . The trading volume for the day was 40.7 K. The trading history from December 5, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 4.58% . The overall trading delta against the current closing price is 11.11% . |
Addex Therapeutics Fundamentals Correlations and Trends
By evaluating Addex Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Addex Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Addex financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Addex Therapeutics Stock history
Addex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Addex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Addex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Addex Therapeutics stock prices may prove useful in developing a viable investing in Addex Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 74.3 M | 78 M | |
| Net Loss | -18.7 M | -17.8 M |
Addex Therapeutics Stock Technical Analysis
Addex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Addex Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Addex Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Addex Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Addex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Addex Therapeutics shares will generate the highest return on investment. By undertsting and applying Addex Therapeutics stock market strength indicators, traders can identify Addex Therapeutics entry and exit signals to maximize returns
Addex Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Addex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Addex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Addex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | (0.26) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (21.85) | Revenue Per Share 1.2 | Quarterly Revenue Growth (0.82) | Return On Assets (0.62) | Return On Equity (1.26) |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.